Pharmacotherapy of different types of thyroiditis;Medikamentöse therapie der thyreoiditiden

Arzneimitteltherapie

Volumn 27, Issue 1, 2009, Pages 3-12

  Derwahl, Karl Michael ^a,b  

^a Universitätsmedizin Berlin ^*

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Follow up; Hashimoto's thyroiditis; Infectious thyroiditis; Painful subacute thyroiditis; Postpartum thyroiditis; Silent sporadic thyroiditis; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMIODARONE; ANTIBIOTIC AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; DICLOFENAC; INTERLEUKIN 2; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIOTRIX; LITHIUM; LITHIUM ACETATE; LITHIUM CARBONATE; PERCHLORATE; POTASSIUM PERCHLORATE; PREDNISOLONE; PREDNISONE; PROPYLTHIOURACIL; PROTHYRID; PROTON PUMP INHIBITOR; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; SELENATE; THIAMAZOLE; THYROTROPIN; THYROZOL; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; ATROPHIC THYROIDITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BACTERIAL THYROIDITIS; CHOLESTATIC HEPATITIS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG MONITORING; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; GASTRITIS; HASHIMOTO DISEASE; HUMAN; ISCHEMIC HEART DISEASE; PANCYTOPENIA; POSTPARTUM THYROIDITIS; REVIEW; RIEDEL GOITER; SILENT THYROIDITIS; STRAHLEN THYROIDITIS; SUBACUTE THYROIDITIS; THROMBOCYTOPENIA; THYROID DISEASE; THYROIDITIS; UNSPECIFIED SIDE EFFECT;

EID: 77953411632     PISSN: 07236913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Alexander WD, McG Harden R, Koutras DA, Wayne E. Influence of iodine intake after treatment with antithyroid drugs. Lancet 1965;2:866.
2. American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists. Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium. Thyroid 2004;14:486.
3. Amrhein JA, Kenny F, Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr 1970;76:54.
4. 3 in normal subjects: a clue to the understanding of subclinical disease. J Clin Endocrinol Metab 2002;87:1068-72.
5. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001;344:1743-9.
6. Atkins MB, Mier JW, Parkinson DR, Gould JA, et al. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988;318:1557-63.
7. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993;77:334-8.
8. Blakesley V, Awni W, Locke C, Ludden T, et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 2004;14:191-200.
9. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U. S. adults. Diabetes Care 2007;30:829-34.
10. Blizzard R, Hung M, Chandler R, AcetoT jr., et al. Hashimoto's thyroiditis. Clinical and laboratory response to prolonged cortisone therapy. N Engl J Med 1962;267:1015-20.
11. Blumberg K, Mayer W, Parikh D, Schell L. Liothyronine and levothyroxine in Armour thyroid. J Pharm Sci 1987;76:346-7.
12. Browning M, Bennet W, Lirklady A, Jung R. Intra-individual variation of thyroxin, triiodothyronine and thyrotropin in treated hypothyroid patients: implications for monitoring replacement therapy. Clin Chem 1988;34:696-9.
13. Buchanan WW, Harden RM. Primary hypothyroidism and Hashimoto's thyroiditis. Arch Intern Med 1965:115:411.
14. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange A jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424-9.
15. Bunevicius R, Prange A. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000;3:167-74.
16. Carr K, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage : comparison of the thyrotrophin releasing hormone tests using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endcrinol 1988;28:325.
17. Centanni M, Gargano L, Canettieri G, Viceconti N, et al. Thyroxine in goiter, Helicobacter pylori infection and chronic gastritis. N Engl J Med 2006;354:1787-95.
18. Cherk MH, Kalff V, Yap KS, Bailey M, et al. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post surgical I-131 ablation therapy for differentiated thyroid carcinoma. Clin Endocrinol (Oxf) (2008 Apr 12 vorab im Internet veröffentlicht).
19. Cooper DS. Which antithyroid drug? Am J Med 1986;80:1165-8.
20. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007;32:49-65.
21. Derwahl KM, Duntas LH (ed.). The thyroid and the cardiovascular risk. Stuttgart: Georg Thieme Verlag, 2005.
22. Derwahl KM, Heufelder A (Hrsg.). Autoimmunerkrankungen der Schilddrüse. Bremen: Uni-Med Verlag, 2006.
23. Gartner R, Gasnier BC, Dietrich JW, Krebs B, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687-91.
24. Escobar-Morreale H, del Rey F, Obregon M, de Escobar G. Only the combined treatment with thyroxine an triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 1996;137:2490-502.
25. Fish L, Schwartz H, Cavanaugh J, Steffels M, et al. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Eng J Med 1987;316:764-70.
26. Duntas LH, Mantzou E, Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 2003;148:389-93.
27. Godley AF, Stanbury JB. Preliminary experience in the treatment of hyperthyroidism with potassium Perchlorate. J Clin Endocrinol Metab 1954;14:70.
28. Girod D, Bigler S, Coltrera M. Riedel's thyroiditis: Report of a lethal case a review of the literature. Otolaryngol Head Neck Surg 1992;107:591-5.
29. Grebe SKG, Cooke RR, Ford HC, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 1997;82:870-5.
30. Hak AE, Pols HA, Visser TJ, Drexhage HA, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-8.
31. Hansen P, Brix T, Sorensen T, Kyvik K, et al. Major genetic influence on the regulation of the pitiutary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab 2004;89:1181-7.
32. Hays M. Thyroid hormone and the gut. Endocr Res 1988;14:203-24.
33. Hays M. Localization of human thyroxine absorption. Thyroid 1991;1:241-8.
34. Hennessey JV, Burman KD, Wartofsky L. The equivalency of two L-thyroxine preparations. Ann Intern Med 1985;102:770-3.
35. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-1.
36. Huber G, Staub JJ, Meier C, Mitrache C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies J Clin Endocrinol Metab 2002;87:3221-6.
37. Kitchener MI, Chapman IM. Subacute thyroiditis: a review of 105 cases Clin Nucl Med 1989;14:439-42.
38. Koytchev R, Lauschner R. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution. Arzneimittelforschung 2004;54:680-4.
39. Krehan A, Dittmar M, Hoppen A, Lichtwald K, et al. Randomisierte, doppelblinde Cross-over-Studie zur Bioverfügbarkeit von Levothyroxin. Med Klin 2002;97:522-7.
40. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998;8:909-13.
41. LeBoff M, Kaplan M, Silva J, Larsen P. Bioavailability of thyroid hormones from oral replacement preparations. Metabolism 1982;31:900-5.
42. Leese GP, Jung RT, Guthrie C, et al. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992;37:500-3.
43. MacKenzie CG, MacKenzie JB. Effect of sulfonamides and thiourea on the thyroid gland and basal metabolism. Endocrinology 1943;32:185.
44. Mandell SJ, Larson PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;323:91-6.
45. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, Garcia-Monzon C, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 1996;44:635-42.
46. Martino E, Buratti L, Bartalena L, Mariotti S, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest 1987;10:321-3.
47. McCowen KC. Garber JR, Spark R. Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline. N Engl J Med 1997;337:1010-1.
48. Mikosch P. Schilddrüse und Amiodaron-Therapie: Diagnostik, Therapie und Möglichkeiten zum klinischen Management. Wien Med Wochenschr 2008;158:29-35.
49. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001;22:605-30.
50. Nayak B, Hodak SP. Hyperthyroidism. Endocrinol Metab Clin North Am 2007;36:617-56.
51. Nishihara E, Ohye H, Amino N, Takata K, etal. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 2008;47:725-9 (2008 Apr 16 vorab im Internet veröffentlicht).
52. Othman S, Phillips DI, Parkes AB, Richards CJ, et al. A long-term follow-up of postpartum thyroiditis Clin Endocrinol (Oxf) 1990;32:559-64.
53. Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid 2001;11:249-55.
54. Saravanan P, Chau W, Roberts N, Vedhara K, et al. Psychological well-being in patients on 'adequate' doses of 1-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57:577-85.
55. Sawka A, Gerstein H, Marriott M, MacQueen G, et al. Does a combination regimen of thyroxine (T4) and 3,5,3′triiodothytonine improve despressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4551-5.
56. Stagnaro-Green A. Clinical review 152: Postpartum thyroiditis. J Clin Endocrinol Metab 2002;87:4042-7.
57. Stranges S, Marshal J, Natarajan R, Donahue R, et al. Effects of long-term selenium supplementation in the incidence of type 2 diabetes. Ann Intern Med 2007;147:217-23.
58. Thomas MC, Mathew TH, Russ GR. Changes in thyroxine requirements in patients with hypothyroidism undergoing renal transplantation. Am J Kidney Dis 2002;39:354-7.
59. Toft A. Thyroid hormone replacement - one hormone or two? N Engl J Med 1999;340:469-70.
60. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 2007;36:1051-66.
61. Topliss DJ, Wright JA, Volpe R. Increased requirement for thyroid hormone after a jejunal bypass operation. Can Med Assoc J 1980;123:765-6.
62. Volpe R, Row W, Ezrin C. Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab 1967;27:1275-84.
63. Volpe R. The management of subacute (De Quervain's) thyroiditis. Thyroid 1993;3:253-5.
64. Walsh J, Shiels L, Lim E, Bhagat C, et al. Combined thyroxine/ liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone; a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003;88:4543-50.
65. Wiberg JJ, Nuttall FQ. Methimazole toxicity from high doses. Ann Intern Med 1972;77:414-6.
66. Yamanda T, Ikejiri K, Kotani M, Kusakabe T. An increase of plasma triiodothyronine and thyroxine after administration of dexamethasone to hypothyreoid patients with Hashimoto thyroiditis. J Clin Endocrinol Metab 1981;46:784.